| pubmed-article:9706135 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9706135 | lifeskim:mentions | umls-concept:C0024299 | lld:lifeskim |
| pubmed-article:9706135 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:9706135 | lifeskim:mentions | umls-concept:C0393073 | lld:lifeskim |
| pubmed-article:9706135 | lifeskim:mentions | umls-concept:C0011306 | lld:lifeskim |
| pubmed-article:9706135 | lifeskim:mentions | umls-concept:C1879348 | lld:lifeskim |
| pubmed-article:9706135 | lifeskim:mentions | umls-concept:C0332161 | lld:lifeskim |
| pubmed-article:9706135 | lifeskim:mentions | umls-concept:C0079411 | lld:lifeskim |
| pubmed-article:9706135 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9706135 | pubmed:dateCreated | 1998-8-28 | lld:pubmed |
| pubmed-article:9706135 | pubmed:abstractText | The use of immunosuppressive therapies after solid organ transplantation has been shown to increase a patient's risk for Epstein-Barr virus (EBV)-associated lymphoma. A potential therapy for this disorder is the adoptive transfer of EBV-specific cytotoxic T lymphocytes (CTLs). We proposed that dendritic cells (DCs) could be loaded with EBV antigens and be used to improve the in vitro generation of EBV-specific CTLs. | lld:pubmed |
| pubmed-article:9706135 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9706135 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9706135 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:9706135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9706135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9706135 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9706135 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9706135 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:9706135 | pubmed:issn | 0039-6060 | lld:pubmed |
| pubmed-article:9706135 | pubmed:author | pubmed-author:McKinnonK PKP | lld:pubmed |
| pubmed-article:9706135 | pubmed:author | pubmed-author:MahonSS | lld:pubmed |
| pubmed-article:9706135 | pubmed:author | pubmed-author:LyerlyH KHK | lld:pubmed |
| pubmed-article:9706135 | pubmed:author | pubmed-author:GelberCC | lld:pubmed |
| pubmed-article:9706135 | pubmed:author | pubmed-author:IacobucciMM | lld:pubmed |
| pubmed-article:9706135 | pubmed:author | pubmed-author:WheatleyG... | lld:pubmed |
| pubmed-article:9706135 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9706135 | pubmed:volume | 124 | lld:pubmed |
| pubmed-article:9706135 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9706135 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9706135 | pubmed:pagination | 171-6 | lld:pubmed |
| pubmed-article:9706135 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:meshHeading | pubmed-meshheading:9706135-... | lld:pubmed |
| pubmed-article:9706135 | pubmed:year | 1998 | lld:pubmed |
| pubmed-article:9706135 | pubmed:articleTitle | Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma. | lld:pubmed |
| pubmed-article:9706135 | pubmed:affiliation | Department of Surgery, Duke University Medical Center, Durham, NC, USA. | lld:pubmed |
| pubmed-article:9706135 | pubmed:publicationType | Journal Article | lld:pubmed |
